Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2000
02/24/2000CA2340095A1 Canine growth hormone secretagogue receptor
02/24/2000CA2339904A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids
02/24/2000CA2339579A1 Improved microbial catalyst for desulfurization of fossil fuels
02/24/2000CA2339518A1 Gene
02/24/2000CA2339414A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence
02/24/2000CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
02/24/2000CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions
02/24/2000CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000CA2339350A1 High level secretory expression system of intact mk family protein
02/24/2000CA2339338A1 Vanadate resistance glycosylation 4 gene
02/24/2000CA2339337A1 Drug targets in candida albicans
02/24/2000CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
02/24/2000CA2339302A1 Vascular endothelial growth factor 3
02/24/2000CA2338386A1 Proteases and associated proteins
02/24/2000CA2338184A1 Bacterial superantigen vaccines
02/24/2000CA2333914A1 Dna shuffling to produce herbicide selective crops
02/24/2000CA2333832A1 Pesticidal toxins and genes from bacillus laterosporus strains
02/24/2000CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
02/23/2000EP0980912A1 Alkaline ceramidase (E.C. 3.5.1.23) gene from Pseudomonas aeruginosa
02/23/2000EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges
02/23/2000EP0980436A1 Increased production of proteins by using chaperone-like proteins
02/23/2000EP0980433A1 Uncoupling protein homologue: ucp 3
02/23/2000EP0980432A1 Chimeric opg polypeptides
02/23/2000EP0980431A1 Antimicrobial peptide
02/23/2000EP0980430A1 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
02/23/2000EP0980429A2 Human toll-like receptor proteins, related reagents and methods
02/23/2000EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
02/23/2000EP0980423A1 Methods for producing phospholipid metabolites in yeast
02/23/2000CN1245533A Mammalian chemokines
02/23/2000CN1245532A Reduction of phosphorus containing components in edible oils comprising high amount of non-hydratable phosphorus by use of phospholipase from filamentous fungus having phospholipase A and/or B activit
02/23/2000CN1245502A DNA encoding lepidopteran-active delta-endotoxins and its use
02/23/2000CN1245399A Method of biological control
02/23/2000CN1245398A Method of biological control
02/23/2000CN1245393A Hypersensitive response induced resistance in plants by seed treatment
02/23/2000CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B
02/23/2000CN1049684C Process for preparing high active cellulase
02/23/2000CN1049646C Nanural plant nutritive element fertilizer and its producing method
02/22/2000US6028246 Transformed plant cell, comprising in its genome, a dna sequence encoding a crystal protein which is toxic to lepidoptera
02/22/2000US6028169 Chemokine β-6 antagonists
02/22/2000US6028097 Method of immunosuppression
02/22/2000US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis
02/22/2000US6027938 Micropathological patient replica based on unadulterated whole blood
02/22/2000US6027925 Production of non-native bacterial exopolysaccharide in a recombinant bacterial host
02/22/2000US6027920 System for protein expression and secretion especially in corynebacteria
02/22/2000US6027919 BMP-12 and BMP-13 proteins and DNA encoding them
02/22/2000US6027918 Dna molecule encoding a thermostable enzyme from the genus sulfolobus; vectors and transformed host cells; releases trehalose from nonreducing saccharides having trehalose as an end unit and a degree of glucose polymerization of at least 3
02/22/2000US6027917 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
02/22/2000US6027912 Gene encoding an invertebrate alpha1 calcium channel subunit
02/22/2000US6027910 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
02/22/2000US6027909 Bacillus strain and sporulation assay method
02/22/2000US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders
02/22/2000US6027750 Systems and methods for the rapid isolation of nucleic acids
02/22/2000CA1340910C Fibronectin binding protein
02/22/2000CA1340906C Fibronectin binding protein as well as its preparation
02/22/2000CA1340903C Process for stabilizing a plasmid present in a bacterial strain and strain thus obtained
02/19/2000CA2280350A1 Microbial production of actinol
02/17/2000WO2000008444A1 Fluorescent assay for biological systems
02/17/2000WO2000008443A1 Multiple frequency fluorescence lifetime imaging
02/17/2000WO2000008212A1 Gel microdrops in genetic analysis
02/17/2000WO2000008201A1 Method for obtaining high-molecular biologically active immunomodulating polysaccharides from saccharomyces cerevisiae yeast
02/17/2000WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a)
02/17/2000WO2000008198A1 Polyhydroxyalkanoate production from polyols
02/17/2000WO2000008196A2 Urate oxidase
02/17/2000WO2000008184A1 Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch
02/17/2000WO2000008183A1 Mutant e.coli strains, and their use for producing recombinant polypeptides
02/17/2000WO2000008181A2 Chp polypeptide, a ligand of pak65
02/17/2000WO2000008180A2 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
02/17/2000WO2000008179A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases
02/17/2000WO2000008178A2 Murine dna molecules encoding polypeptides having kinase functions
02/17/2000WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000WO2000008175A2 Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
02/17/2000WO2000008173A1 Identification and functional characterization of a novel ribosomal s6 protein kinase
02/17/2000WO2000008171A1 N-acetylglycosaminyl transferase genes
02/17/2000WO2000008170A1 Gene participating in the production of homo-glutamic acid and utilization thereof
02/17/2000WO2000008168A1 Improvements to strains of streptomyces through the use of biosynthetic genes of tylosine
02/17/2000WO2000008164A2 Thermostable in vitro complex with polymerase activity
02/17/2000WO2000008159A2 Production and use of modified cystatins
02/17/2000WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000WO2000008152A1 Novel orphan cytokine receptors
02/17/2000WO2000008149A2 Human neuronal acid-sensitive cationic channels, its cloning and applications
02/17/2000WO2000008148A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications
02/17/2000WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000WO2000008145A2 Novel genes in control of hematopoiesis
02/17/2000WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3
02/17/2000WO2000008143A2 Gene isolated on the short arm of human chromosome 17
02/17/2000WO2000008139A1 Tumor necrosis factor-gamma
02/17/2000WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE
02/17/2000WO2000008054A1 Modified green fluorescent protein
02/17/2000WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof
02/17/2000WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
02/17/2000WO2000007606A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
02/17/2000WO2000007571A2 Formulations having probiotically active microorganisms
02/17/2000WO2000007545A2 Apoptosis proteins
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000WO1999061624A3 Polyhydroxyalkanoate biopolymer compositions
02/17/2000WO1999058691A3 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
02/17/2000WO1999058675A3 Human genes and gene expression products v
02/17/2000WO1999058643A8 Microorganism producing docosahexaenoic acid and phospholipase a1, liquid culture medium thereof, process for preparing phospholipid and process for producing 2-acyllysophospholipid
02/17/2000WO1999053036A9 Ste20-related protein kinases